iifl-logo

DSP Healthcare Fund Direct G

DSP Healthcare Fund Direct G

Fund Name

DSP Mutual Fund

Scheme Name

DSP Healthcare Fund Direct G

AMC

DSP Mutual Fund

Type

:  Open

Category

Equity - Pharma

Launch Date

12-Nov-2018

Fund Manager

Chirag Dagli

Net Assets (Rs. cr)

3142.36

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

DSP Healthcare Fund Direct G - Nav Details

Nav Date

:  05-Jun-2026

NAV [Rs.]

:  46.244

Buy/Resale Price [Rs.]

0

Sell/Repurchase Price [Rs.]

0

Entry Load %

Nil

Exit Load %

1.00% - If redeemed/switched out within 12 months from the date of allotment. Nil - If redeemed/switched out after 12 months from the date of allotment.

DSP Healthcare Fund Direct G- NAV Chart

DSP Healthcare Fund Direct G- Performance(%)

Returns above 1 yr. are annualized

1W
1M
3M
6M
1Y
3Y
5Y
Since INC
Scheme Returns
1.49
5.05
11.1
5.07
10.09
23.65
15.85
22.59
Category Avg
-1.48
3.96
6.4
5.15
10
23.45
13.95
14.83
Category Best
-0.02
6.29
10.67
11.79
20.13
27.28
16.38
29.32
Category Worst
-2.63
-0.92
-0.53
-2.66
1.77
19.09
10.35
-1.67

DSP Healthcare Fund Direct G- Latest Dividends

No Records Found

DSP Healthcare Fund Direct G- Investment Details

Min. Investment(Rs.)

100

Increm.Investment(Rs.)

100

In & Out

In

InName Of The CompanyNo Of Shares
--

Out

InName Of The CompanyNo Of Shares
--

Fund Holdings

Asset Type
Instrument Name
Industry
Net Assets(%)
No of Shares
Mkt Value(Cr.)
Equity & Equity related Investments
EquitySun Pharma.Inds.Pharmaceuticals & Biotechnology8.841535592277.68
EquityIpca Labs.Pharmaceuticals & Biotechnology8.261696381259.69
EquityCiplaPharmaceuticals & Biotechnology7.561813462237.49
Foreign EquityGlobus Medical IncHealthcare Equipment & Supplies7.35268800230.86
EquityLaurus LabsPharmaceuticals & Biotechnology6.421832618201.76
Foreign EquityIllumina IncHealthcare Services6.16160400193.61
EquitySai LifePharmaceuticals & Biotechnology6.101792251191.67
EquityGland PharmaPharmaceuticals & Biotechnology5.13920673161.19
EquityCohance LifePharmaceuticals & Biotechnology4.833140630151.77
EquityApollo HospitalsHealthcare Services4.73194767148.73
EquityAlembic PharmaPharmaceuticals & Biotechnology3.431428180107.82
EquityVijaya Diagnost.Healthcare Services3.36935530105.67
EquityPfizerPharmaceuticals & Biotechnology3.0120064494.51
EquityKovai MedicalHealthcare Services2.9716515693.43
EquityP & G Health LtdPharmaceuticals & Biotechnology2.6415928883.09
Foreign EquityIntuitive Surgical IncHealthcare Equipment & Supplies2.601876881.79
EquityIndoco RemediesPharmaceuticals & Biotechnology2.16323347467.73
EquityEmcure PharmaPharmaceuticals & Biotechnology2.0137669863.28
EquityConcord BiotechPharmaceuticals & Biotechnology1.8149668856.72
EquityICICI LombardInsurance1.3524141342.56
EquityNephrocare HealtHealthcare Services1.0763498333.60
EquityUnichem Labs.Pharmaceuticals & Biotechnology1.0685206333.23
EquityAarti DrugsPharmaceuticals & Biotechnology1.0285215532.06
Foreign EquityAbbott LaboratoriesPharmaceuticals & Biotechnology0.873160027.32
EquityAlkem LabPharmaceuticals & Biotechnology0.643733420.16
EquityMedplus HealthRetailing0.5319207816.75
EquityJupiter Life LinHealthcare Services0.379411711.53
EquityLaxmi DentalHealthcare Equipment & Supplies0.182804015.57
EquityCorona RemediesPharmaceuticals & Biotechnology0.15273144.71
Foreign EquityGrail IncHealthcare Services0.1487334.53

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

MY WEALTH AT RETIREMENT

Calculate the worth of your wealth at retirement

Key information

Fund House:
DSP Mutual Fund
Incorporation Date:
13-May-1996
Total Assets Managed (Cr.):
2,28,622.33
Trustee/s:
Mr.T.S. Krishna Murthy, DSP Trustee Private Limit, Shitin D. Desai, S.S.N. Moorthy, Mrs. Pravin tripathi, Ms. Dharmishta Rawal
Chairman:
NA
CEO / MD:
Mr. Kalpen Parekh
CIO:
NA
President:
NA
Director/s:
Uday Khanna, Mr.Hemendra M. Kothari, Mr. S.S. Mundra, Ms. Aditi Kothari Desai, Mr.Dhananjay Mungale, Mr. S. Ramadorai
Compliance Officer/s:
Pritesh Majmudar
Investor Service Officer/s:
NA
Fund Manager/s:
Chirag Dagli
Auditors:
S.R. BATLIBOI &Co.LLP, M/s.Walker Chandiok & Co.

OTHER INFORMATION

Registered Office:
The Ruby, 25th Floor, 29, Senapati Bapat Marg, Dadar (West), Mumbai - 400028.
Contact Nos:
022-66578000
Fax:
022-66578181
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.